KIDS250117P20000
- 0.00
- 0.000.00%
OrthoPediatrics Newsroom
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
Needham Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $42
Piper Sandler Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Cuts Target Price to $40
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
OrthoPediatrics (KIDS) Gets a Buy From Piper Sandler
Needham Reiterates Buy on OrthoPediatrics, Maintains $42 Price Target
OrthoPediatrics Analyst Ratings
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $25
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
The Latest Analyst Ratings For OrthoPediatrics
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
Needham Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $42
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
Truist Financial Sticks to Their Hold Rating for OrthoPediatrics (KIDS)
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
OrthoPediatrics: Strong Financial Performance and Growth Outlook Reinforce Buy Rating
OrthoPediatrics Is Maintained at Hold by Truist Securities
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Cuts Target Price to $28
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34